...Alliance's Alliance Pharmaceuticals Ltd. subsidiary acquired all rights to Syntometrine oxytocin/ergometrine from Novartis for $11.5 million...

...rights to market NVS's Syntometrine oxytocin/ ergometrine in the U.K. for £2 million ($3.8 million). Syntometrine...